Pennsylvania State agency seeks to gain control of Medicaid managed care plans' prescription drug benefits

The administration of Pennsylvania Gov. Ed Rendell (D) has proposed shifting control of the prescription drug component of Medicaid managed care plans to the state Department of Public Welfare, the Pittsburgh Post-Gazette reports.

According to department officials, the change would enhance services, simplify requirements for medical providers and save the state an estimated $95 million annually.

The state already administers pharmacy benefits for about 800,000 other Medicaid beneficiaries. State Medicaid agencies can negotiate larger rebates from drug manufacturers than managed care plans. The rebates would make up the bulk of the estimated $95 million in savings. Under the proposal, the managed care plans would have "real-time" access to the state's pharmacy claims data and could use the data to ensure patients receive the most appropriate medications for their conditions, Mike Nardone, the department's deputy secretary for medical assistance programs, said.

Estelle Richman, secretary of the agency, said the program would be simplified by establishing a single statewide list of preferred drugs and a list of procedures to submit claims and request prior authorization of certain medications. The formularies would not be as restrictive as those used by managed care plans, she said.

Managed care officials oppose the idea, saying that shifting oversight of the benefits to the welfare department would reduce options for beneficiaries (Fahy, Pittsburgh Post-Gazette, 5/21).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
More than half of all US adults are eligible for semaglutide therapy